The Applied Medical Research Center (CIMA) of the University of Navarra and Amsterdam Molecular Therapeutics BV (AMT) have demonstrated the efficacy of a periodic and acute antiporphyria treatment in the preclinical phase. Once the toxicological and clinical phase has elapsed, the disease may end definitively. The clinical phase is expected to begin in 2008 and treatment will be available in 2010.